STAT Plus: Bayer to invest in Boston lab focused on chronic lung conditions

German pharmaceutical giant Bayer AG will invest more than $30 million over the next five years to create a lab at Brigham and Women’s Hospital to develop drugs to treat chronic lung diseases.

The lab in the Longwood Medical Area will employ about 20 scientists from Bayer, Brigham, and Massachusetts General Hospital. The three organizations will equally share the rights to any discoveries made as part of the venture.

Continue to STAT Plus to read the full story…

Read Original Article: STAT Plus: Bayer to invest in Boston lab focused on chronic lung conditions »